bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2019: M A M F J
2018: D N O S A J J M

 
  Other news for:
Family Planning
Acquired Immunodeficiency Syndrome
 Resources from HONselect
Vaginal Ring That Targets Pregnancy, HIV Seems Safe: Study

By Robert Preidt

FRIDAY, Oct. 26, 2018 (HealthDay News) -- An experimental vaginal ring meant to prevent pregnancy and HIV looks safe, according to an early stage study.

The dual-purpose ring releases the antiretroviral drug dapivirine and the contraceptive hormone levonorgestrel, said researchers led by Dr. Sharon Achilles, of the University of Pittsburgh School of Medicine.

"We are very encouraged by our findings in this first-in-human study of the dapivirine-levonorgestrel ring," said Achilles, an assistant professor of obstetrics, gynecology and reproductive sciences.

The ring is designed to provide 90 days' protection at a time.

This small, 14-day trial involving 24 women who were not pregnant and not infected with HIV was the first clinical study of the ring. Its use resulted in sufficient levels of levonorgestrel to prevent pregnancy and adequate levels of dapivirine to reduce risk of HIV infection, the researchers reported.

There were no safety concerns, and the ring was well-tolerated, according to the Microbicide Trials Network study. The research was funded by the U.S. National Institutes of Health and presented Wednesday at an HIV prevention conference, in Madrid, Spain.

The researchers have started a second Phase 1 trial in which women will use the ring for 90 days.

"With a second study underway, we are another step closer to potentially having an easy-to-use product that can provide safe and effective, long-acting protection against both HIV and unintended pregnancy," Achilles said in a network news release.

Research presented at meetings is usually considered preliminary until published in a peer-reviewed medical journal.

More information

The U.S. Office on Women's Health has more on HIV/AIDS.

SOURCE: Microbicide Trials Network, news release, Oct. 24, 2018

Copyright © 2018 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=738925

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Contraceptive Devices, Female
Research Personnel
Women
Acquired Immunodeficiency Syndrome
Levonorgestrel
Infection
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact